Global Fragment-based Drug Discovery Industry Market Trends, Analysis & Statistics 2018-2023


Report ID : RNR-225995 Category : Machinery Equipment Published Date : 31-Oct-18
Publisher : S&P Consulting Pages : 96 Format : PDF
In the Global Fragment-based Drug Discovery Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
Global Fragment-based Drug Discovery Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Sygnature Discovery
Kinetic Discovery Ltd.
Emerald BioStructures Inc.
Evotec AG
Crown Bioscience Inc.
Sprint Bioscience
Beactica AB
Astex Pharmaceuticals
Proteros Fragments GmbH
...

Global Fragment-based Drug Discovery Market: Product Segment Analysis
Biophysical techniques
Non-biophysical techniques
Type 3 
 

Global Fragment-based Drug Discovery Market: Application Segment Analysis
Biopharmaceutical Companies
CROs
Academic and Research Institutions 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
Global Fragment-based Drug Discovery Industry Market Analysis & Forecast 2018-2023

Chapter 1 Fragment-based Drug Discovery Market Overview
1.1 Product Overview and Scope of Fragment-based Drug Discovery
1.2 Fragment-based Drug Discovery Market Segmentation by Type in 2016
1.2.1 Global Production Market Share of Fragment-based Drug Discovery by Type in 2016
1.2.1 Biophysical techniques
1.2.2 Non-biophysical techniques
1.2.3 Type 3
1.3 Fragment-based Drug Discovery Market Segmentation by Application in 2016
1.3.1 Fragment-based Drug Discovery Consumption Market Share by Application in 2016
1.3.2 Biopharmaceutical Companies 
1.3.3 CROs
1.3.4 Academic and Research Institutions
1.4 Fragment-based Drug Discovery Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Fragment-based Drug Discovery (2013-2023)
1.5.1 Global Product Sales and Growth Rate (2013-2023)
1.5.2 Global Product Revenue and Growth Rate (2013-2023)
Chapter 2 Global Economic Impact on Fragment-based Drug Discovery Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Fragment-based Drug Discovery Market Competition by Manufacturers
3.1 Global Fragment-based Drug Discovery Production and Share by Manufacturers (2016 and 2017)
3.2 Global Fragment-based Drug Discovery Revenue and Share by Manufacturers (2016 and 2017)
3.3 Global Fragment-based Drug Discovery Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Fragment-based Drug Discovery Manufacturing Base Distribution, Production Area and Product Type
3.5 Fragment-based Drug Discovery Market Competitive Situation and Trends
3.5.1 Fragment-based Drug Discovery Market Concentration Rate
3.5.2 Fragment-based Drug Discovery Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Fragment-based Drug Discovery Production, Revenue (Value) by Region (2013-2018)
4.1 Global Fragment-based Drug Discovery Production by Region (2013-2018)
4.2 Global Fragment-based Drug Discovery Production Market Share by Region (2013-2018)
4.3 Global Fragment-based Drug Discovery Revenue (Value) and Market Share by Region (2013-2018)
4.4 Global Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.5 North America Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.5.1 North AmericaFragment-based Drug DiscoveryProduction and Market Share by Manufacturers
4.5.2 North AmericaFragment-based Drug DiscoveryProduction and Market Share by Type
4.5.3 North AmericaFragment-based Drug DiscoveryProduction and Market Share by Application
4.6 Europe Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.6.1 EuropeFragment-based Drug DiscoveryProduction and Market Share by Manufacturers
4.6.2 Europe Fragment-based Drug Discovery Production and Market Share by Type
4.6.3 Europe Fragment-based Drug Discovery Production and Market Share by Application
4.7 China Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.7.1 ChinaFragment-based Drug DiscoveryProduction and Market Share by Manufacturers
4.7.2 China Fragment-based Drug Discovery Production and Market Share by Type
4.7.3 China Fragment-based Drug Discovery Production and Market Share by Application
4.8 Japan Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.8.1 Japan Fragment-based Drug Discovery Production and Market Share by Manufacturers
4.8.2 Japan Fragment-based Drug Discovery Production and Market Share by Type
4.8.3 Japan Fragment-based Drug Discovery Production and Market Share by Application
4.9 Southeast Asia Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.9.1 Southeast Asia Fragment-based Drug Discovery Production and Market Share by Manufacturers
4.9.2 Southeast Asia Fragment-based Drug Discovery Production and Market Share by Type
4.9.3 Southeast Asia Fragment-based Drug Discovery Production and Market Share by Application
4.10 India Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2013-2018)
4.10.1 India Fragment-based Drug Discovery Production and Market Share by Manufacturers
4.10.2 India Fragment-based Drug Discovery Production and Market Share by Type
4.10.3 India Fragment-based Drug Discovery Production and Market Share by Application
Chapter 5 Global Fragment-based Drug Discovery Supply (Production), Consumption, Export, Import by Regions (2013-2018)
5.1 Global Fragment-based Drug Discovery Consumption by Regions (2013-2018)
5.2 North America Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)
5.3 Europe Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)
5.4 China Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)
5.5 Japan Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)
5.6 Southeast Asia Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)
5.7 India Fragment-based Drug Discovery Production, Consumption, Export, Import by Regions (2013-2018)

Chapter 6 Global Fragment-based Drug Discovery Production, Revenue (Value), Price Trend by Type
6.1 Global Fragment-based Drug Discovery Production and Market Share by Type (2013-2018)
6.2 Global Fragment-based Drug Discovery Revenue and Market Share by Type (2013-2018)
6.3 Global Fragment-based Drug Discovery Price by Type (2013-2018)
6.4 Global Fragment-based Drug Discovery Production Growth by Type (2013-2018)

Chapter 7 Global Fragment-based Drug Discovery Market Analysis by Application
7.1 Global Fragment-based Drug Discovery Consumption and Market Share by Application (2013-2018)
7.2 Global Fragment-based Drug Discovery Revenue and Market Share by Type (2013-2018)
7.3 Global Fragment-based Drug Discovery Consumption Growth Rate by Application (2013-2018)
7.4 Market Drivers and Opportunities
7.4.1 Potential Applications
7.4.2 Emerging Markets/Countries

Chapter 8 Global Fragment-based Drug Discovery Manufacturers Analysis
8.1 Sygnature Discovery
8.1.1 Company Basic Information, Manufacturing Base and Competitors
8.1.2 Product Type, Application and Specification
8.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.1.4 Business Overview
8.2 Kinetic Discovery Ltd.
8.2.1 Company Basic Information, Manufacturing Base and Competitors
8.2.2 Product Type, Application and Specification
8.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.2.4 Business Overview
8.3 Emerald BioStructures Inc.
8.3.1 Company Basic Information, Manufacturing Base and Competitors
8.3.2 Product Type, Application and Specification
8.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.3.4 Business Overview
8.4 Evotec AG
8.4.1 Company Basic Information, Manufacturing Base and Competitors
8.4.2 Product Type, Application and Specification
8.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.4.4 Business Overview
8.5 Crown Bioscience Inc.
8.5.1 Company Basic Information, Manufacturing Base and Competitors
8.5.2 Product Type, Application and Specification
8.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.5.4 Business Overview
8.6 Sprint Bioscience
8.6.1 Company Basic Information, Manufacturing Base and Competitors
8.6.2 Product Type, Application and Specification
8.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.6.4 Business Overview
8.7 Beactica AB
8.7.1 Company Basic Information, Manufacturing Base and Competitors
8.7.2 Product Type, Application and Specification
8.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.7.4 Business Overview
8.8 Astex Pharmaceuticals
8.8.1 Company Basic Information, Manufacturing Base and Competitors
8.8.2 Product Type, Application and Specification
8.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.8.4 Business Overview
8.9 Proteros Fragments GmbH
8.9.1 Company Basic Information, Manufacturing Base and Competitors
8.9.2 Product Type, Application and Specification
8.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
8.9.4 Business Overview
?

Chapter 9 Fragment-based Drug Discovery Manufacturing Cost Analysis
9.1 Fragment-based Drug Discovery Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Price Trend of Key Raw Materials
9.1.3 Key Suppliers of Raw Materials
9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.2.1 Raw Materials
9.2.2 Labor Cost
9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Fragment-based Drug Discovery

Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers
10.1 Fragment-based Drug Discovery Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Fragment-based Drug Discovery Major Manufacturers in 2016
10.4 Downstream Buyers

Chapter 11 Marketing Strategy Analysis, Distributors/Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List

Chapter 12 Market Effect Factors Analysis
12.1 Technology Progress/Risk
12.1.1 Substitutes Threat
12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

Chapter 13 Global Fragment-based Drug Discovery Market Forecast (2018-2023)
13.1 Global Fragment-based Drug Discovery Production, Revenue Forecast (2018-2023)
13.2 Global Fragment-based Drug Discovery Production, Consumption Forecast by Regions (2018-2023)
13.3 Global Fragment-based Drug Discovery Production Forecast by Type (2018-2023)
13.4 Global Fragment-based Drug Discovery Consumption Forecast by Application (2018-2023)
13.5 Fragment-based Drug Discovery Price Forecast (2018-2023)

Chapter 14 Appendix